While We Are Waiting for the Superbug: Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

While We Are Waiting for the Superbug : Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance. / Jensen, Carsten Strøby.

I: Journal of Common Market Studies, Bind 58, Nr. 6, 2020, s. 1361–1376 .

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, CS 2020, 'While We Are Waiting for the Superbug: Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance', Journal of Common Market Studies, bind 58, nr. 6, s. 1361–1376 . https://doi.org/10.1111/jcms.13041

APA

Jensen, C. S. (2020). While We Are Waiting for the Superbug: Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance. Journal of Common Market Studies, 58(6), 1361–1376 . https://doi.org/10.1111/jcms.13041

Vancouver

Jensen CS. While We Are Waiting for the Superbug: Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance. Journal of Common Market Studies. 2020;58(6):1361–1376 . https://doi.org/10.1111/jcms.13041

Author

Jensen, Carsten Strøby. / While We Are Waiting for the Superbug : Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance. I: Journal of Common Market Studies. 2020 ; Bind 58, Nr. 6. s. 1361–1376 .

Bibtex

@article{10e98d7506404a2090fce60a68707dbc,
title = "While We Are Waiting for the Superbug: Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance",
abstract = "This article analyses how constitutional asymmetry in EU health policy affects EU-governmental initiatives to combat antimicrobial resistance (AMR). AMR has been viewed as one of the biggest threats to public health that will arise during the next two to three decades, both within the EU and globally. During the last decade the EU has taken a number of initiatives to combat AMR. The article finds that constitutional asymmetry in health policy has a major influence on how EU-AMR policies are developed and implemented. Policies relating to promotion initiatives (like selling pharmaceuticals in the EU) are implemented through hard law types of governance (directives and regulations), while policies more directly aiming at reducing the consumption of antimicrobials are implemented through soft law initiatives (open methods of coordination).",
keywords = "antimicrobial resistance, constitutional asymmetry in EU, EU combat against AMR, health policy, use of antimicrobials",
author = "Jensen, {Carsten Str{\o}by}",
year = "2020",
doi = "10.1111/jcms.13041",
language = "English",
volume = "58",
pages = "1361–1376 ",
journal = "Journal of Common Market Studies",
issn = "0021-9886",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - While We Are Waiting for the Superbug

T2 - Constitutional Asymmetry and EU Governmental Policies to Combat Antimicrobial Resistance

AU - Jensen, Carsten Strøby

PY - 2020

Y1 - 2020

N2 - This article analyses how constitutional asymmetry in EU health policy affects EU-governmental initiatives to combat antimicrobial resistance (AMR). AMR has been viewed as one of the biggest threats to public health that will arise during the next two to three decades, both within the EU and globally. During the last decade the EU has taken a number of initiatives to combat AMR. The article finds that constitutional asymmetry in health policy has a major influence on how EU-AMR policies are developed and implemented. Policies relating to promotion initiatives (like selling pharmaceuticals in the EU) are implemented through hard law types of governance (directives and regulations), while policies more directly aiming at reducing the consumption of antimicrobials are implemented through soft law initiatives (open methods of coordination).

AB - This article analyses how constitutional asymmetry in EU health policy affects EU-governmental initiatives to combat antimicrobial resistance (AMR). AMR has been viewed as one of the biggest threats to public health that will arise during the next two to three decades, both within the EU and globally. During the last decade the EU has taken a number of initiatives to combat AMR. The article finds that constitutional asymmetry in health policy has a major influence on how EU-AMR policies are developed and implemented. Policies relating to promotion initiatives (like selling pharmaceuticals in the EU) are implemented through hard law types of governance (directives and regulations), while policies more directly aiming at reducing the consumption of antimicrobials are implemented through soft law initiatives (open methods of coordination).

KW - antimicrobial resistance

KW - constitutional asymmetry in EU

KW - EU combat against AMR

KW - health policy

KW - use of antimicrobials

U2 - 10.1111/jcms.13041

DO - 10.1111/jcms.13041

M3 - Journal article

AN - SCOPUS:85083960602

VL - 58

SP - 1361

EP - 1376

JO - Journal of Common Market Studies

JF - Journal of Common Market Studies

SN - 0021-9886

IS - 6

ER -

ID: 247338794